Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Nobuaki TakehanaTomoyasu FukuiYusaku MoriMunenori HiromuraMichishige TerasakiMakoto OharaMichiya TakadaMasako TomoyasuYoshihisa ItoTetsuro KobayashiSho-Ichi YamagishiPublished in: Journal of diabetes investigation (2023)
Similar to GADA, 3 Screen ICA may be a useful diagnostic tool for detecting patients with SPIDDM.